FDA Approves New Pancreatic Cancer Drug After Stunning Trial Results

The therapy is a brand new targeted drug for the disease which experts have labelled as a substantial breakthrough following doubling of survival time in a trial.

Unrivaled Basketball Valued At $650 Million After New Funding Round, League Says

Unrivaled surpasses its $100 million Series C target, reaching a $650 million valuation as the player-owned women’s basketball league prepares for its 3rd season in 2027.

How To Make Money Taking Surveys And Where To Start

Looking to make extra money online? Explore 10 legitimate paid survey sites, how much you can earn, payout options and what to know before signing up.

iPhone 18 Release Date Confirmation Slashes Your iPhone Price

Apple’s iPhone 18 release date confirmation started a clock that watches your current phone’s value rapidly drop. Here’s what to do.

Johnny Furphy In A Good Place With ACL Rehab Ahead Of Pacers Season

Young Indiana Pacers forward Johnny Furphy is back on the court as he rehabs from a torn ACL suffered in February.

As Employer Health Costs Rise, Worker Cancer Cases An Increasing Worry

Cancer is the top condition driving healthcare spending for the fifth year in a row, a new report from the Business Group on Health shows.

Today’s NYT Connections Answers Explained: Thursday, August 27

Not sure what today’s NYT Connections answers are all about? Find out just what the different words in today’s grid mean and how they fit together.

The End Of Robotic Process Automation? Not Even Close. Here’s What’s Actually Changing

The future of enterprise automation will be defined by AI, workflow platforms and automation technologies working together as complementary capabilities

Myth Busting The SaaSpocalypse: Software Will Not Be Replaced By AI, But It Will Be Reimagined

AI’s success is not a binary, either-or scenario in which one industry group will win at the expense of the others.

VCs Are So Obsessed With This AI Assistant That Its Valuation Jumped Fivefold In Weeks

A hot new AI agent called Instinct was valued at $500 million earlier in August, sources say. Now it’s raising a new round at a $2.5 billion valuation from Benchmark and Index.